TP0501 - Pharmaco-Scintigraphic-Study

NCT02306772 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: TP05 Coating A
DRUG: TP05 Coating B

Sponsor

Tillotts Pharma AG